TABALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia ~ 6/9/22 @ 6:30pmSocial Media CoordinatorMay 23, 20221 min readClick here to register today!
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
Comments